Digisonics and Medis have partnered to provide a comprehensive single system solution that adds cardiac MR to Digisonics congenital Echo and Cath system. 

NEW YORK, October 4, 2017 — Peerbridge Health Inc., a Health IT company, announced today that its first product, The Peerbridge Cor™ System—a wireless electrocardiogram (ECG) monitor—has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

Despite many physicians’ reticence to recommend annual electrocardiograms as part of a yearly physical, a study conducted in Canada proved that more than one in five annual health exams lead to one.

A man born with a congenital heart murmur developed systemic arterial hypertension as an adult. At age 50, he went to the hospital because of dyspnea. He also had a pulmonic valve ejection click and murmur of pulmonic stenosis. When at the hospital, his echocardiogram showed hypertrophy of both ventricles as well as an enlarged right atrium.

The first report to address long-term outcomes for patients with severe native mitral regurgitation (MR) who are treated with transcatheter mitral valve replacement has found that post-procedural reductions in MR held up over time, with no significant recurrence upon two-year follow-up.

WESTLAKE, Texas, Aug. 17, 2017 — HeartSciences today announced the European launch of MyoVista® high sensitivity electrocardiograph (hsECG™) Testing Device, developed in response to the global unmet need for effective, low-cost, front-line screening of cardiac disease in both symptomatic and asymptomatic patients.

AUM Cardiovascular has received clearance from the U.S. Food and Drug Administration (FDA) for its acoustic and ECG device to detect heart murmurs.